VITAL LIVING INC
CHEN AGREEMENT
<DOCUMENT>
<TYPE>EX-10
<SEQUENCE>6
<FILENAME>ex10-30.txt
<DESCRIPTION>CHEN AGREEMENT
<TEXT>
                            CONSULTING AGREEMENT


     THIS CONSULTING AGREEMENT ("Agreement") executed as of this 19th day  of
May,  2002,  is  made by and between Stephen Songsheng Chen,  also  known  as
Stephen  S. Chen  ("Consultant") and Vital Living, Inc., a Nevada corporation
("Company").

                               R E C I T A L S

      Company  desires  to  utilize Consultant's  experience,  knowledge  and
abilities  in  the  various aspects of its business.  Consultant  desires  to
render  such consulting services subject to the terms and conditions of  this
Agreement.

     In  consideration of the foregoing recitals and the mutual covenants and
agreements contained herein, Consultant and Company agree as follows:

1.        CONSULTING SERVICES.

 (A)    The Company retains Consultant to provide the following consulting
services (the "Consulting Services") to the Company:

(1)  Assist Vital Living in establishing an office and presence in China.

(2)  Assist Vital Living with meeting the legal requirements of being able to
do business in China.

(3)  Facilitate the introduction and negotiation of Strategic alliances in
China.

(4)  Board of Director/Advisor Placement for the Chinese Company to be
established for Vital Living.

(5)  Finance: Assist the Company in identifying and assessing opportunities
for capital formation for execution of the Chinese sales and distribution
strategy.

(6)  Corporate Legal Services

(7)   Competitive Research and analysis of the Chinese Marketplace.

(8)  Assist in the establishing of a marketing and sales force within China.

(9)  Executive Search for positions for our Chinese operations.

(10) Facilitate introductions to leading physicians and other prominent
healthcare industry professionals, including the recruiting of highly
qualified individuals to serve as members of the Scientific Advisory Board
within China. Additionally, to facilitate the introduction of additional
medical institutes and clinics who would wish to participate in the
distribution of Vital Living nutraceuticals to their patients in China.

<PAGE>

(11) Perform such additional services as the Company and Consultant may agree
upon.

     (b)  In performing the duties required under this Agreement, Consultant, at
all  times shall exercise his professional independent judgment, based on his
training,  experience and expertise.  Consultant shall at  all  times  comply
with  the  ethical  rules and opinions of the professional  organizations  of
which  he  is  a member.  If any conflict arises between Consultant's  duties
hereunder   and  Consultant's  ethical  or  other  contractual   obligations,
Consultant shall immediately bring the matter to the attention of  the  chief
executive  officer, president or chairman of the board of  directors  of  the
Company.

     (c)   Consultant  shall  devote such time as is reasonably  required  to
perform the Consulting Services.

     (d)   Consultant shall provide the Consulting Services at such locations
as  may  be  necessary  or  desirable  to perform  such  Consulting  Services
effectively.

2.   TERM AND TERMINATION.

     (A)   This  Agreement shall commence on the execution date  hereof  (the
"Effective  Date")  and shall automatically terminate (the period  commencing
upon  the  Effective Date and ending upon termination of this Agreement,  the
"Term")  upon the termination of the two year period following the  Effective
Date, or earlier as follows:

(i)  by the Company at any time, with or without Cause (as defined below),
provided  that a termination of this Agreement for Cause shall  be  effective
immediately upon written notice from the Company to the Consultant.

(ii) upon the death or disability of the Consultant.

(iii)     by mutual agreement of the Company and Consultant.

(iv) by Consultant for any reason, provided that a termination of this
Agreement by the Consultant shall be effective only upon 30 days written
notice from the Consultant to the Company.

  (b)  For purposes of this Agreement, Company shall have "Cause" to terminate
this Agreement upon Consultant's:

(i)  Commission of a felony involving moral turpitude; or

(ii) death; provided that the Consultant's beneficiaries shall be entitled to
exercise the Consultant's due stock options through the last day of the month
in which his death occurs; or

(iii)     Commission of any act of fraud, theft, or embezzlement involving
assets of the Company; or

<PAGE>

(iv) Becoming physically or mentally disabled so that he is unable to perform
his services for (I) a period of 60 consecutive days, or (II) for shorter
periods aggregating 60 days during any twelve-month period.  The Consultant
shall become physically or mentally disabled so that he is unable
substantially to perform his services for (i) a period of 30 consecutive
days, or (ii) for shorter periods aggregating 30 days during any twelve-month
period.  Notwithstanding such disability the Company shall continue to pay
the Consultant his compensation through the date of such termination.

 (c)  Upon the expiration or termination of this Agreement for any reason, (a)
each  party will be released from all obligations to the other arising  after
the  date of expiration or termination, except that expiration or termination
of  this  Agreement  will not relieve either party of its  obligations  under
Sections  3(b),  3(c),  6,  7, 8, or 9, nor will  expiration  or  termination
relieve  Consultant or Company from any liability arising from any breach  of
this  Agreement;  and  (b) Consultant will promptly  notify  Company  of  all
Confidential  Information and Subject Inventions, in Consultant's  possession
and  promptly deliver to Company, or destroy at Company's request,  all  such
materials.

3.   OPTION.

     Concurrently with the execution of this Agreement, the Company and
Consultant shall enter into the Nonqualified Stock Option  Agreement attached
hereto as Exhibit A.

4.   INDEPENDENT CONTRACTOR RELATIONSHIP.

     (A)  The relationship of Consultant to Company is that of an independent
contractor  and advisor only.  Nothing contained in this Agreement  shall  be
construed  to  create the relationship of employer and employee or  principal
and  agent between Consultant and Company.  Accordingly, Consultant shall not
be  entitled  to  any  employee benefits, such as  medical  or  other  health
insurance, available to employees of Company.  In addition, Consultant is not
a  member,  partner or joint venturer with Company, and nothing contained  in
this  Agreement  shall be construed so as to make such  parties  partners  or
joint  venturers  or  to  impose any liability as such  on  either  of  them.
Consultant  shall  have  no  authority to  bind  Company  to  any  agreement,
obligation or commitment.

(b)  It is understood and agreed that Consultant's duties and obligations to
Company are fully expressed by the terms hereof.  As long as Consultant's
other business activities or services do not cause substantial interference
with Consultant's performance of his duties under this Agreement or otherwise
violate any other agreement between the Consultant and the Company,
Consultant shall be entitled to engage in any other business activities he
deems fit, as an owner, officer, director, partner, investor, employee,
consultant or otherwise.

(c)  Consultant shall be responsible for payment of any and all applicable
federal, state and local income and other taxes, business license fees and
workers' compensation and disability benefits which he may incur as a
consequence of rendering the Consulting Services provided for herein.  In the
event that the Company is required to pay, or it is contended that the
Company is required to pay any such employee taxes, penalties, interest,
fines or assessments, Consultant agrees to hold harmless and indemnify the
Company in full from and against any such taxes, penalties, fines or

<PAGE>

assessments, and attorneys' fees and other expenses which result from, or are
incident to, any proceeding to establish or collect such taxes.

5.   CONFIDENTIALITY.

     (A)  "Confidential Information" shall mean all confidential or proprietary
information  of the Company whether developed by the Company,  by  Consultant
within  the  scope  of Consultant's engagement by the Company,  or  by  third
parties  for  the  Company,  including  without  limitation  knowledge  about
business,   marketing   plans,  pricing  practices,  products,   formulation,
ingredients,  formulations, dosages, sources, methods  of  manufacturing  and
delivery, inventions, prototypes, formula, processes, programming techniques,
experimental work, as well as information relating to the customers,  clients
and suppliers of Company. Confidential Information will not include, however,
any  information  which is or becomes part of the public  domain  through  no
fault  of Consultant or that Company regularly gives to third parties without
restriction on use or disclosure.

(b)  Consultant agrees to hold all such Confidential Information in strict
confidence, not to disclose it to others or use it in any way, except in
performing the Services, and not to allow any unauthorized person access to
it, either before or after expiration or termination of this Agreement.
Consultant further agrees to take all action reasonably necessary and
satisfactory to protect the confidentiality of the Confidential Information.

6.   ASSIGNMENT OF INVENTIONS.

(A)  "Inventions" shall mean all designs, discoveries, inventions, computer
programs,  procedures, improvements (whether or not patentable or whether  or
not  copyrightable),  modifications,  enhancements,  products,  developments,
drawings,  notes,  documents, information and materials, including  any  such
items relating to the ingredients, formulations, dosages, sources, methods of
manufacturing  and delivery of Nutraceuticals, whether or not patentable  and
whether or not reduced to practice, together with each literary work of  such
owner, whether or not copyrightable.

(b)  "Subject Inventions" shall mean all Inventions made by Consultant during
the Term that result from any work performed by Consultant for the Company or
were developed using the Company's equipment, supplies, facilities, or trade
secret information.

(c)  Consultant hereby assigns to the Company, without additional
consideration to the Consultant, the entire right, title, and interest in and
to the Subject Inventions and all confidential information, writings,
apparatus, and other matter related to the Subject Inventions and in and to
all proprietary rights therein or based thereon.  Consultant understands and
agrees that all materials included in any Subject Invention which is eligible
for protection under the Copyright Laws shall be deemed specially
commissioned by the Company and treated as "Works for Hire" under the
Copyright Laws of the United States to the extent such materials fall within
a category eligible for such treatment. In the event that such materials are
not eligible to be treated as a Work for Hire, Consultant nonetheless shall,
and hereby does, assign all of Consultant's interest in such work to the
Company as the same is created by Consultant.

<PAGE>

(d)  During and after the Term, Consultant shall execute and deliver all
written assignments, oaths, declarations, applications, and other documents
as may be prepared by the Company to evidence and/or effect the assignments
required by this Agreement.

(e)  During and after the Term, Consultant shall provide the Company with all
information, documentation, and assistance the Company may request to
perfect, enforce, or defend any Subject Inventions or Proprietary Information
under this Agreement. The Company, in its sole discretion, shall determine
the extent of the proprietary rights, if any, to be protected in or based on
the Subject Inventions and Proprietary Information. All such information,
documentation, and assistance shall be provided at no additional expense to
the Company, except out-of-pocket expenses which  the Consultant incurred at
the Company's request.

(f)  Nothing in this Agreement shall affect in any way the ownership of, or
rights to, any Inventions other than the Subject Inventions.

7.   CONFLICTS OF INTEREST

(A)  During the Term and for two (2) years thereafter, Consultant shall not:

(i)  perform any services for any person or entity competing directly with
the Company; or

(ii) directly or indirectly (other than for Company), sell or attempt to sell
any Nutraceuticals to any person or entity which has been a customer of the
Company during the Term,  purchase or attempt to purchase (other than for
Consultant's personal use) any Nutraceuticals from any person or entity which
has been a vendor or supplier of Company during the Term, or use Consultant's
personal knowledge or influence in relation to any person or entity which has
at any time during such period been a customer, vendor, or supplier of
Company in order to compete with Company.

 (b)  During the Term and for two (2) years thereafter, Consultant shall not:

(i)  directly or indirectly, induce or attempt to induce any employee,
consultant, independent contractor, advisor, or other service provider of the
Company to terminate such person's or entity's relationship with the Company;

(ii) directly or indirectly induce or attempt to induce any vendor, customer,
or supplier, or any other person having a business relationship with Company,
to terminate or adversely modify such person's or entity's relationship with
the Company.

8.   MISCELLANEOUS

(A)  Binding Effect. This Agreement shall inure to the benefit of and shall
be  binding  upon the parties hereto and Company's successors or assigns  and
the  Consultant's heirs, executors and legal representatives,  provided  that
this  Agreement  is a personal services contract and may not be  assigned  by
Consultant without the prior written consent of Company.

<PAGE>

(b)  Publicity.  Consultant shall not publicize or advertise in any manner
that Consultant is performing the Consulting Services hereunder, without the
prior written consent of Company.  Consultant hereby grants to Company the
right to use Consultant's name, likeness, and relationship with Company in
and in connection with technical materials, various reports, brochures or
other documents produced by or on behalf of Company.

(c)  Assignment.  Consultant may not assign this Agreement or any of
Consultant's rights or delegate Consultant's duties under this Agreement
either in whole or in part, whether by operation of law or otherwise, without
the prior written consent of Company.  Any attempted assignment or delegation
without such consent will be void and of no force and effect.

(d)  Equitable Remedies.  Because the Services are personal and unique and
because Consultant will have access to Confidential Information of Company,
Company will have the right to enforce this Agreement and any of its
provisions by injunction, specific performance or other equitable relief
without prejudice to any other rights and remedies that Company may have for
a breach of this Agreement.

(e)  Attorneys' Fees.  If any action is necessary to enforce the terms of
this Agreement, the substantially prevailing party will be entitled to
reasonable attorneys' fees, costs and expenses in addition to any other
relief to which such prevailing party may be entitled.

(f)  Governing Law; Severability.  This Agreement will be governed by and
construed in accordance with the laws of the State of Nevada excluding that
body of law pertaining to conflict of laws.  If any provision of this
Agreement is for any reason found to be unenforceable, the remainder of this
Agreement will continue in full force and effect.

(g)  Notices.  All notices and demands between the parties hereto shall be in
writing and shall be served either by registered or certified mail, and such
notices or demands shall be deemed given and made forty-eight (48) hours
after the deposit thereof in the United States mail, postage prepaid,
addressed to the party to whom such notice or demand is to be given or made,
and the issuance of the registered receipt therefor.  All notices and demands
to Consultant or the Company may be given to them at the following addresses:

If to Consultant:     Stephen Songsheng Chen, also known as Stephen S. Chen
                      2099 Strathshire Hall Lane
                      Powell, OH  43065

If to Company:        Vital Living, Inc.
                      2800 S. Rural Rd.
                      Tempe, AZ  85282

(h)   Counterparts.   This  Agreement may be executed  in  two  or  more
counterparts,  each of which shall be deemed an original, but  all  of  which
together shall constitute one and the same document.

(i)  Captions.  The captions in this Agreement are for convenience of
reference only and shall not define or limit any of the terms or provisions
thereof.

<PAGE>

(j)  Modification. Any waiver, modification or amendment of any provision of
this Agreement will be effective only if in writing and signed by the parties
hereto.


     IN  WITNESS WHEREOF, the parties hereto have executed this Agreement  as
of the date and year first written.





VITAL LIVING, INC., a Nevada corporation



/S/Bradley D. Edson
Bradley D. Edson, C.E.O.



CONSULTANT


/S/Stephen Songsheng Chen
Stephen Songsheng Chen, also known as Stephen S. Chen

<PAGE>


                                  Exhibit A

                     NONQUALIFIED STOCK OPTION AGREEMENT


     THIS NONQUALIFIED STOCK OPTION AGREEMENT ("Agreement") is entered into
as of May 19, 2002 (the "Grant Date"), by and between VITAL LIVING, INC., a
Nevada corporation ("Company"), and Stephen Songsheng Chen, also known as
Stephen S. Chen  ("Optionee").

                               R E C I T A L S

     A.   On May 3, 2002, the Board of Directors of the Company adopted the
Vital Living, Inc. 2002 Stock Option Plan (the "Plan").

     B.   Pursuant to the Plan, on May 3, 2002, the Board of Directors of the
Company  acting  as the Plan Committee ("Committee") authorized  granting  to
Optionee options to purchase shares of the common stock, $0.001 par value, of
the  Company ("Shares") for the term and subject to the terms and  conditions
hereinafter set forth.

                              A G R E E M E N T

     It is hereby agreed as follows:

1.    CERTAIN  DEFINITIONS.  Unless otherwise defined herein, or the  context
otherwise  clearly requires, terms with initial capital letters  used  herein
shall have the meanings assigned to such terms in the Plan.

2.   GRANT OF OPTIONS.  The Company hereby grants to Optionee, a Nonqualified
Option  ("Options") to purchase all or any part of 200,000 Shares,  upon  and
subject  to  the  terms and conditions of the Plan, which is incorporated  in
full  herein  by this reference, and upon the other terms and conditions  set
forth  herein.  The Option is not intended to qualify as an "incentive  stock
option"  as that term is defined in Section 422 of the Internal Revenue  Code
of 1986, as amended from time to time.

3.   OPTION PERIOD/VESTING.

     3.1   Subject  to  the  provisions of Section 8, the  Options  shall  be
exercisable to purchase the Vested Shares at any time prior to expiration  of
the  five  (5)  year period commencing upon the Grant Date  (the  "Expiration
Date"), unless earlier terminated pursuant to Section 7.

     3.2   Shares of Common Stock underlying this Option shall become "Vested
Shares"  as  follows:  (a) so long as Holder is engaged  by  the  Corporation
pursuant to the Consulting Agreement to which this Option is an Exhibit  (the

<PAGE>

"Consulting  Agreement  ), "Option Shares" shall vest  in  24  equal  monthly
installments of 8,333 shares, with the first installment beginning  June  19,
2002,  with  additional installments on the 19th day of each  calendar  month
thereafter, and the last installment for 8,341 shares.

4.    METHOD  OF EXERCISE.  The Options shall be exercisable by  Optionee  by
giving  written notice to the Company of the election to purchase and of  the
number  of  Shares Optionee elects to purchase, such notice to be accompanied
by  such  other executed instruments or documents as may be required  by  the
Committee  pursuant to this Agreement, and unless otherwise directed  by  the
Committee,  Optionee shall at the time of such exercise tender  the  purchase
price  of  the  Shares he has elected to purchase.  An Optionee may  purchase
less  than  the  total number of Shares for which the Option is  exercisable,
provided  that a partial exercise of an Option may not be for less  than  One
Hundred (100) Shares.  If Optionee shall not purchase all of the Shares which
he  is  entitled  to purchase under the Options, his right  to  purchase  the
remaining unpurchased Shares shall continue until expiration of the  Options.
The  Options  shall  be exercisable with respect of whole  Shares  only,  and
fractional Share interests shall be disregarded.

5.    AMOUNT OF PURCHASE PRICE.  The purchase price per Share for each  Share
which  Optionee  is  entitled to purchase under the Options  shall  be  Three
Dollars ($3.00) per Share.

6.    PAYMENT OF PURCHASE PRICE. At the time of Optionee's notice of exercise
of  the  Options, Optionee shall exercise the Option by notifying the Company
of  the  number of shares that he desires to purchase and by delivering  with
such notice the cash or a certified bank check payable to the Company for the
purchase  price  of the shares being purchased. The Company,  upon  receiving
payment,  shall make immediate delivery of such purchased shares, fully  paid
and non-assessable, registered in the name of Optionee.

7.   REGISTRATION OF SHARES. The terms of the Registration Agreement attached
hereto as Exhibit A are hereby incorporated herein.

8.   EFFECT OF TERMINATION OF EMPLOYMENT.

     8.1   If an Optionee's employment or other relationship with the Company
or  a  Subsidiary terminates, the effect of the termination on the Optionee's
rights to acquire Shares shall be as follows:
          (a)    Termination   by   the  Company  Other   Than   For   Cause.
Notwithstanding Section 3.2 above, if Optionee is terminated by  the  Company
other  than for Cause (as defined in the Consulting Agreement Agreement),  or
if  Optionee terminates his engagement pursuant to Section 3(a)(iii)  of  the
Consulting Agreement Agreement, than:

(1)  the number of shares that are Vested Shares as of the date of
termination shall be the total number of shares that will vest.

(2)  Optionee's Options shall expire upon the Expiration Date.  Prior to the
Expiration Date, Optionee may exercise his Options, but only with respect to
the Vested Shares, taking into account the acceleration provision of Section

<PAGE>

8.1(a)(1) and except as so exercised.
          (b)    Other   Termination.   If  Optionee's  employment   by,   or
relationship  with,  the  Company or a Subsidiary is  terminated  for  Cause,
Optionee's  Option  shall  expire thirty (30) days  after  such  termination;
however,  the  Committee may waive the expiration of  the  Option  by  giving
written  notice  of such waiver to Optionee.  In the event  of  such  waiver,
Optionee may exercise the Option only to such extent, for such time, and upon
such  terms and conditions as if such Optionee had ceased to be employed  by,
or  ceased to have a relationship with, the Company or a Subsidiary upon  the
date of such termination for a reason other than for cause.

9.    NON-TRANSFERABILITY OF OPTIONS.  The Options shall not be transferable,
either voluntarily or by operation of law, otherwise than by will or the laws
of  descent  and distribution and shall be exercisable during the  Optionee's
lifetime only by Optionee.

10.   ADJUSTMENTS UPON CHANGES IN CAPITALIZATION.  As used herein,  the  term
"Adjustment Event" means an event pursuant to which the outstanding Shares of
the  Company  are  increased, decreased or changed into, or exchanged  for  a
different  number  or  kind  of  shares or  securities,  without  receipt  of
consideration    by    the    Company,   through   reorganization,    merger,
recapitalization, reclassification, stock split, reverse stock  split,  stock
dividend,  stock  consolidation or otherwise.   Upon  the  occurrence  of  an
Adjustment Event, (i) appropriate and proportionate adjustments shall be made
to  the  number  and kind and exercise price for the shares  subject  to  the
Options,  and (ii) appropriate amendments to this Agreement shall be executed
by  the  Company  and  Optionee  if the Committee  determines  that  such  an
amendment  is  necessary  or  desirable  to  reflect  such  adjustments.   If
determined  by the Committee to be appropriate, in the event of an Adjustment
Event  which  involves the substitution of securities of a corporation  other
than  the  Company, the Committee shall make arrangements for the assumptions
by such other corporation of the Options.  Notwithstanding the foregoing, any
such  adjustment  to the Options shall be made without change  in  the  total
exercise price applicable to the unexercised portion of the Options, but with
an  appropriate  adjustment  to the number of  shares,  kind  of  shares  and
exercise  price for each share subject to the Options.  The determination  by
the  Committee  as to what adjustments, amendments or arrangements  shall  be
made pursuant to this Section 10, and the extent thereof, shall be final  and
conclusive.   No  fractional Shares shall be issued on account  of  any  such
adjustment or arrangement.

11.  NO RIGHTS TO CONTINUED EMPLOYMENT OR RELATIONSHIP. Nothing contained  in
this  Agreement  shall  obligate  the  Company  to  employ  or  have  another
relationship  with Optionee for any period or interfere in any way  with  the
right  of  the Company to reduce Optionee's compensation or to terminate  the
employment of or relationship with Optionee at any time.

12.   TIME OF GRANTING OPTIONS.  The time the Options shall be deemed granted
shall be the Grant Date.

13.   PRIVILEGES OF STOCK OWNERSHIP.  Optionee shall not be entitled  to  the
privileges  of  stock  ownership as to any Shares  not  actually  issued  and
delivered to Optionee.  No Shares shall be purchased upon the exercise of any
Options  unless and until, in the opinion of the Company's counsel, any  then

<PAGE>

applicable  requirements of any laws, or governmental or regulatory  agencies
having jurisdiction, and of any exchanges upon which the stock of the Company
may be listed shall have been fully complied with.

14.   SECURITIES  LAWS COMPLIANCE.  The Company will diligently  endeavor  to
comply  with  all  applicable  securities laws before  any  stock  is  issued
pursuant  to the Options.  Without limiting the generality of the  foregoing,
the  Company may require from the Optionee such investment representation  or
such agreement, if any, as counsel for the Company may consider necessary  in
order  to comply with the Securities Act of 1933 as then in effect,  and  may
require that the Optionee agree that any sale of the Shares will be made only
in  such manner as is permitted by the Committee.  The Committee may  in  its
discretion cause the Shares underlying the Options to be registered under the
Securities Act of 1933 as amended by filing a Form S-8 Registration Statement
covering  the Options and the Shares underlying the Options.  Optionee  shall
take  any  action  reasonably  requested by the Company  in  connection  with
registration or qualification of the Shares under federal or state securities
laws.

15.   PLAN  CONTROLS.  The Options shall be subject to and  governed  by  the
provisions of the Plan.  All determinations and interpretations of  the  Plan
made by the Committee shall be final and conclusive.

16.  SHARES SUBJECT TO LEGEND.  The certificates evidencing such shares shall
bear  the  following restrictive legend,  unless and until such  shares  have
been  registered in accordance with the Securities and Exchange Act of  1933,
as amended (the "Act"):

THE  SHARES OF STOCK REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED
UNDER  THE SECURITIES ACT OF 1933, AS AMENDED, (THE "ACT"), OR THE SECURITIES
LAWS  OF  ANY OTHER JURISDICTION, AND MAY NOT BE SOLD, TRANSFERRED,  PLEDGED,
HYPOTHECATED,  OR  OTHERWISE  DISPOSED OF  IN  ANY  MANNER  UNLESS  THEY  ARE
REGISTERED  UNDER  SUCH  ACT  AND  THE  SECURITIES  LAWS  OR  ANY  APPLICABLE
JURISDICTIONS OR UNLESS PURSUANT TO ANY EXEMPTION THEREFROM.

17.   COMPLIANCE WITH APPLICABLE LAWS. THE CORPORATION'S OBLIGATION TO  ISSUE
SHARES  OF  ITS  COMMON  STOCK  UPON EXERCISE OF  THE  OPTIONS  IS  EXPRESSLY
CONDITIONED  UPON  THE COMPLETION BY THE CORPORATION OF ANY  REGISTRATION  OR
OTHER  QUALIFICATION  OF SUCH SHARES UNDER ANY STATE AND/OR  FEDERAL  LAW  OR
RULINGS OR REGULATIONS OF ANY GOVERNMENTAL REGULATORY BODY, OR THE MAKING  OF
SUCH INVESTMENT REPRESENTATIONS OR OTHER REPRESENTATIONS AND UNDERTAKINGS  BY
THE OPTIONEE OR ANY PERSON ENTITLED TO EXERCISE THE OPTION IN ORDER TO COMPLY
WITH  THE  REQUIREMENTS OF ANY EXEMPTION FROM ANY SUCH REGISTRATION OR  OTHER
QUALIFICATION  OF  SUCH  SHARES  WHICH  THE  COMMITTEE  SHALL,  IN  ITS  SOLE
DISCRETION,  DEEM NECESSARY OR ADVISABLE.  SUCH REQUIRED REPRESENTATIONS  AND
UNDERTAKINGS MAY INCLUDE REPRESENTATIONS AND AGREEMENTS THAT THE OPTIONEE  OR
ANY  PERSON ENTITLED TO EXERCISE THE OPTION (i) IS NOT PURCHASING SUCH SHARES

<PAGE>

FOR DISTRIBUTION AND (ii) AGREES TO HAVE PLACED UPON THE FACE AND REVERSE  OF
ANY  CERTIFICATES A LEGEND SETTING FORTH ANY REPRESENTATIONS AND UNDERTAKINGS
WHICH HAVE BEEN GIVEN TO THE COMMITTEE OR A REFERENCE THERETO.

18.  MISCELLANEOUS.

     18.1  Further Acts.  Each party agrees to perform any further  acts  and
execute  and  deliver any documents which may be necessary to carry  out  the
provisions of this Agreement.

     18.2  Binding Effect. This Agreement shall inure to the benefit  of  and
shall  be binding upon the parties hereto and Company's successors or assigns
and  the  Consultant's  heirs, executors and legal representatives,  provided
that  this Agreement is a personal services contract and may not be  assigned
by Consultant without the prior written consent of Company.

     18.3  Attorneys' Fees.  If any action is necessary to enforce the  terms
of  this  Agreement, the substantially prevailing party will be  entitled  to
reasonable  attorneys'  fees, costs and expenses in  addition  to  any  other
relief to which such prevailing party may be entitled.

     18.4  Governing Law; Severability.  This Agreement will be  governed  by
and  construed  in accordance with the laws of the State of Nevada  excluding
that  body of law pertaining to conflict of laws.  If any provision  of  this
Agreement is for any reason found to be unenforceable, the remainder of  this
Agreement will continue in full force and effect.

     18.5  Notices.  All notices and demands between the parties hereto shall
be in writing and shall be served either by registered or certified mail, and
such notices or demands shall be deemed given and made forty-eight (48) hours
after  the  deposit  thereof  in  the United States  mail,  postage  prepaid,
addressed to the party to whom such notice or demand is to be given or  made,
and the issuance of the registered receipt therefor.  All notices and demands
to Consultant or the Company may be given to them at the following addresses:

If to Optionee:     Stephen Songsheng Chen, also known as Stephen S. Chen
                    2099 Strathshire Hall Lane
                    Powell, OH  43065


If to Company:      Vital Living, Inc.
                    2800 S. Rural Rd.
                    Tempe, AZ  85282

     18.6  Counterparts.   This  Agreement may be executed  in  two  or  more
counterparts,  each of which shall be deemed an original, but  all  of  which
together shall constitute one and the same document.

     18.7  Captions.   The captions in this Agreement are for convenience  of
reference  only and shall not define or limit any of the terms or  provisions
thereof.

<PAGE>

     18.8  Modification.   Any  waiver,  modification  or  amendment  of  any
provision  of this Agreement will be effective only if in writing and  signed
by the parties hereto.



        IN  WITNESS WHEREOF, the parties have entered into this Agreement  as
of the date first set forth above.

                         "COMPANY"

                         VITAL LIVING, INC.,
                         a Nevada corporation



                         By:/S/Bradley D. Edson
                           Bradley D. Edson, C.E.O.


                         "OPTIONEE"



                         /S/Stephen Songsheng Chen
                         Stephen Songsheng Chen, also
                         known as Stephen S. Chen


<PAGE>

                             EXHIBIT A TO OPTION

                        REGISTRATION RIGHTS AGREEMENT

1.   DEFINITIONS.

     CAPITALIZED TERMS NOT DEFINED IN THIS EXHIBIT A  SHALL HAVE THE MEANING
SET FORTH IN THE OPTION TO WHICH THIS EXHIBIT IS ATTACHED.   FOR PURPOSES OF
THIS EXHIBIT A:

 (a)  Effective Date.  The term "Effective Date" shall mean the Grant Date of
the Option.

 (b)  Holder.  The term "Holder" shall mean the Optionee.

 (c)  Registration.  The terms "register," "registered," and "registration"
refer to a registration effected by preparing and filing a registration
statement in compliance with the Securities Act of 1933, as amended, (the
"Securities Act"), and the declaration or ordering of effectiveness of such
registration statement.

 (d)  Registrable Securities.  The term "Registrable Securities" means:  (1)
any Common Stock of the Company issued or to be issued upon exercise of the
Option and (2) any shares of Common Stock of the Company issued as (or
issuable upon the conversion or exercise of any option, right or other
security which is issued as) a dividend or other distribution with respect
to, or in exchange for or in replacement of, any shares of Common Stock
described in clause (1) of this paragraph.  Notwithstanding the foregoing,
"Registrable Securities" shall exclude any Registrable Securities sold by a
person in a transaction in which rights under this Exhibit A are not assigned
in accordance with this Agreement.

 (e)  Registrable Securities Then Outstanding.  The number of shares of
"Registrable Securities then outstanding" shall mean the number of shares of
Common Stock of the Company that are Registrable Securities and (l) are then
issued and outstanding or (2) are then issuable pursuant to an exercise of
the Option or pursuant to conversion of securities issuable pursuant to an
exercise of the Option.

 (f)  SEC.  The term "SEC" or "Commission" means the U.S. Securities and
Exchange Commission.

2.   DEMAND REGISTRATIONS.

 (a)  As long as Holder is engaged by the Corporation, at any time after May
10,  2003.   The Holder shall be entitled to one (1) such demand registration
per  twelve  (12) month period (i.e. all registrations must be  at  least  12
months plus one day apart). The Optionee shall have the right to demand  that
the Company  satisfy its obligations pursuant to this Section 3 by use of the
SEC's Form S-8, or any successor form thereto, subject to applicable law,  or
such  other SEC registration statement form as Holder may choose to  request,
including  Form  S-3 or any successor form thereto, or if  Form  S-3  is  not
available, Form S-1 or Form S-2, or any successor form thereto. Holder  shall
notify  the  Company  in writing that it  intends to offer  or  cause  to  be
offered  for  public sale all or any portion of the Registrable  Shares,  and
within ten (10) days of the receipt after such notice.

<PAGE>

(b)  Upon written request of Holder, the Company will use its best efforts to
cause all or any part of the Registrable Securities that may be requested by
Holder to be registered under the Securities Act as expeditiously as
possible.

(c)  If Holder intends to distribute the Registrable Securities covered by
its request by means of an underwriting, it shall so advise the Company as
part of its request.

(d)  Notwithstanding the foregoing, the Company shall not be obligated to
effect, or to take any action to effect, any registration pursuant to this
Section 2:  (i) if the Company shall furnish to Holder a certificate signed
by the President or Chief Executive Officer of the Company stating that in
the good faith judgment of the Board of Directors of the Company, it would be
seriously detrimental to the Company and its stockholders for such
registration statement to be effected at such time, and that it is essential
to the Company to defer the filing, in which event the Company shall have the
unconditional right to defer the filing of the registration statement for a
period of not more than 120 days after receipt of the request of the Holder
under this Section 2; provided, however that the Company shall not utilize
this right more than once in any 12 month period; or (ii) during the period
starting with the date 60 days prior to the Company's good faith estimate of
filing of, and ending on a date 180 days after the effective date of, a
registration statement filed under the Securities Act (other than a
registration relating solely to the sale of securities to participants in a
Company stock plan).

3.   OBLIGATIONS OF THE COMPANY. WHENEVER REQUIRED TO EFFECT THE REGISTRATION
OF ANY REGISTRABLE SECURITIES UNDER THIS AGREEMENT THE COMPANY SHALL, AS
EXPEDITIOUSLY AS POSSIBLE:

(a)  Registration Statement.  Prepare and file with the SEC a registration
statement  with  respect  to such Registrable Securities  and  use  its  best
efforts  to cause such registration statement to become effective,  provided,
however, that the Company shall not be required to keep any such registration
statement effective for more than one (1) year.

(b)  Amendments and Supplements.  Prepare and file with the SEC such
amendments and supplements to such registration statement and the prospectus
used in connection with such registration statement as may be necessary to
comply with the provisions of the Securities Act with respect to the
disposition of all securities covered by such registration statement.

(c)  Prospectuses.  Furnish to the Holders such number of copies of a
prospectus, including a preliminary prospectus, in conformity with the
requirements of the Securities Act, and such other documents as they may
reasonably request in order to facilitate the disposition of the Registrable
Securities owned by them that are included in such registration.

(d)  Blue Sky.  Use its best efforts to register and qualify the securities
covered by such registration statement under such other securities or Blue
Sky laws of such jurisdictions as shall be reasonably requested by the
Holders, provided that the Company shall not be required in connection
therewith or as a condition thereto to qualify to do business or to file a
general consent to service of process in any such states or jurisdictions.

<PAGE>

(e)  Underwriting.  In the event of any underwritten public offering, enter
into and perform its obligations under an underwriting agreement in usual and
customary form, with the managing underwriter(s) of such offering.  Each
Holder participating in such underwriting shall also enter into and perform
its obligations under such an agreement.

(f)  Notification.  Notify each Holder of Registrable Securities covered by
such registration statement at any time when a prospectus relating thereto is
required to be delivered under the Securities Act of the happening of any
event as a result of which the prospectus included in such registration
statement, as then in effect, includes an untrue statement of a material fact
or omits to state a material fact required to be stated therein or necessary
to make the statements therein not misleading in the light of the
circumstances then existing.

(g)  Opinion and Comfort Letter.  Furnish, at the request of any  Holder
requesting  registration of Registrable Securities, on  the  date  that  such
Registrable  Securities are delivered to the underwriters for sale,  if  such
securities are being sold through underwriters, (i) an opinion, dated  as  of
such  date, of the counsel representing the Company for the purposes of  such
registration,  in form and substance as is customarily given to  underwriters
in  an underwritten public offering and reasonably satisfactory to a majority
in  interest  of  the  Holders  requesting  registration,  addressed  to  the
underwriters,  if  any,  and  to  the  Holders  requesting  registration   of
Registrable  Securities, and (ii) a "comfort" letter dated as of  such  date,
from the independent certified public accountants of the Company, in form and
substance as is customarily given by independent certified public accountants
to   underwriters   in  an  underwritten  public  offering   and   reasonably
satisfactory   to   a   majority  in  interest  of  the  Holders   requesting
registration,  addressed  to the underwriters, if any,  and  to  the  Holders
requesting  registration of Registrable Securities.  If such  securities  are
not  being sold through underwriters, then the Company shall furnish, at  the
request  and  at  the sole expense of any Holder requesting  registration  of
Registrable  Securities,  on  the date that the registration  statement  with
respect  to such securities becomes effective, an opinion, dated as  of  such
date,  of  the  counsel  representing the Company for the  purposes  of  such
registration,  in form and substance as is customarily given to  underwriters
in  an underwritten public offering and reasonably satisfactory to a majority
in  interest  of  the  Holders  requesting  registration,  addressed  to  the
underwriters,  if  any,  and  to  the  Holders  requesting  registration   of
Registrable Securities.

4.    FURNISH  INFORMATION.  It shall be a condition  precedent  to  the
obligations  of  the Company to effect the Registration of their  Registrable
Securities  that  the  selling  Holder shall  furnish  to  the  Company  such
information  regarding himself, the Registrable Securities held by  him,  and
the intended method of disposition of such securities as shall be required to
timely effect the Registration of their Registrable Securities.

5.   INDEMNIFICATION.  In the event any Registrable Securities are included
in a registration statement under Section 2:

   (a)   By the Company.  To the extent permitted by law, the Company  will
indemnify and hold harmless each Holder, the partners, officers and directors
of  each  Holder, any underwriter (as determined in the Securities  Act)  for
such  Holder and each person, if any, who controls such Holder or underwriter

<PAGE>

within  the meaning of the Securities Act or the Securities Exchange  Act  of
1934,  as amended, (the "1934 Act"), against any losses, claims, damages,  or
Liabilities  (joint or several) to which they may become  subject  under  the
Securities Act, the 1934 Act or other federal or state law, insofar  as  such
losses, claims, damages, or liabilities (or actions in respect thereof) arise
out  of  or  are  based  upon any of the following statements,  omissions  or
violations (collectively a "Violation"):

(i)  any untrue statement or alleged untrue statement of a material fact
contained   in   such  registration  statement,  including  any   preliminary
prospectus  or  final  prospectus contained  therein  or  any  amendments  or
supplements thereto;

(ii) the omission or alleged omission to state therein a material fact
required to be stated therein, or necessary to make the statements therein
not misleading, or

(iii)     any violation or alleged violation by the Company of the Securities
Act, the 1934 Act, any federal or state securities law or any rule or
regulation promulgated under the Securities Act, the 1934 Act or any federal
or state securities law in connection with the offering covered by such
registration statement;

     and  the  Company will reimburse each such Holder, partner,  officer  or
director,  underwriter or controlling person for any legal or other  expenses
reasonably incurred by them, as incurred, in connection with investigating or
defending  any  such  loss,  claim, damage, liability  or  action;  provided,
however,  that the indemnity agreement contained in this Section 5 shall  not
apply  to  amounts  paid  in  settlement of any  such  loss,  claim,  damage,
liability or action if such settlement is effected without the consent of the
Company  (which consent shall not be unreasonably withheld),  nor  shall  the
Company  be  liable  in  any  such case for any  such  loss,  claim,  damage,
liability  or action to the extent that it arises out of or is based  upon  a
Violation  which  occurs  in  reliance upon and in  conformity  with  written
information  furnished expressly for use in connection with such registration
by such Holder, partner, officer, director, underwriter or controlling person
of such Holder.

(b)  By Selling Holders.  To the extent permitted by law, each selling Holder
will indemnify and hold harmless the Company, each of its directors, each  of
its officers who have signed the registration statement, each person, if any,
who  controls  the  Company within the meaning of  the  Securities  Act,  any
underwriter  and any other Holder selling securities under such  registration
statement  or any of such other Holder's partners, directors or  officers  or
any  person who controls such Holder within the meaning of the Securities Act
or the 1934 Act, against any losses, claims, damages or liabilities (joint or
several)  to  which  the Company or any such director,  officer,  controlling
person,  underwriter  or other such Holder, partner or director,  officer  or
controlling  person  of  such  other Holder  may  become  subject  under  the
Securities Act, the 1934 Act or other federal or state law, insofar  as  such
losses, claims, damages or liabilities (or actions in respect thereto)  arise
out  of or are based upon any Violation, in each case to the extent (and only
to  the extent) that such Violation occurs in reliance upon and in conformity
with  written  information  furnished by such Holder  expressly  for  use  in
connection  with such registration; and each such Holder will  reimburse  any
legal  or  other  expenses reasonably incurred by the  Company  or  any  such
director, officer, controlling person, underwriter or other Holder,  partner,
officer,  director or controlling person of such other Holder  in  connection
with  investigating or defending any such loss, claim, damage,  liability  or
action:  provided,  however, that the indemnity agreement contained  in  this
Section  shall  not  apply to amounts paid in settlement of  any  such  loss,

<PAGE>

claim, damage, liability or action if such settlement is effected without the
consent of the Holder, which consent shall not be unreasonably withheld;  and
provided,  further, that the total amounts payable in indemnity by  a  Holder
under  this  Section 5 in respect of any Violation shall not exceed  the  net
proceeds received by such Holder in the registered offering out of which such
Violation arises.

(c)  Notice.  Promptly after receipt by an indemnified party under this
Section 5 of notice of the commencement of any action (including any
governmental action), such indemnified party will, if a claim in respect
thereof is to be made against any indemnifying party under this Section 5,
deliver to the indemnifying party a written notice of the commencement
thereof and the indemnifying party shall have the right to participate in,
and, to the extent the indemnifying party so desires, jointly with any other
indemnifying party similarly noticed, to assume the defense thereof with
counsel mutually satisfactory to the parties; provided, however, that an
indemnified party shall have the right to retain its own counsel, with the
fees and expenses to be paid by the indemnifying party, if representation of
such indemnified party by the counsel retained by the indemnifying party
would be inappropriate due to actual or potential conflict of interests
between such indemnified party and any other party represented by such
counsel in such proceeding.  The failure to deliver written notice to the
indemnifying party within a reasonable time of the commencement of any such
action shall relieve such indemnifying party of liability to the indemnified
party under this Section 5 to the extent the indemnifying party is prejudiced
as a result thereof, but the omission so to deliver written notice to the
indemnified party will not relieve it of any liability that it may have to
any indemnified party otherwise than under this Section 5.

(d)  Defect Eliminated in Final Prospectus.  The foregoing indemnity
agreements of the Company and Holders are subject to the condition that,
insofar as they relate to any Violation made in a preliminary prospectus but
eliminated or remedied in the amended prospectus on file with the SEC at the
time the registration statement in question becomes effective or the amended
prospectus filed with the SEC pursuant to SEC Rule 424(b) (the "Final
Prospectus"), such indemnity agreement shall not inure to the benefit of any
person if a copy of the Final Prospectus was timely furnished to the
indemnified party and was not furnished to the person asserting the loss,
liability, claim or damage at or prior to the time such action is required by
the Securities Act.

(e)  Contribution.  In order to provide for just and equitable contribution
to joint liability under the Securities Act in any case in which either (i)
any Holder exercising rights under this Agreement, or any controlling person
of any such Holder, makes a claim for indemnification pursuant to this
Section 5 but it is judicially determined (by the entry of a final judgment
or decree by a court of competent jurisdiction and the expiration of time to
appeal or the denial of the last right of appeal) that such indemnification
may not be enforced in such case notwithstanding the fact that this Section 5
provides for indemnification in such case, or (ii) contribution under the
Securities Act may be required on the part of any such selling Holder or any
such controlling person in circumstances for which indemnification is
provided under this Section 5; then, and in each such case, the Company and
such Holder will contribute to the aggregate losses, claims, damages or
liabilities to which they may be subject (after contribution from others) in
such proportion so that such Holder is responsible for the portion
represented by the percentage that the public offering price of its

<PAGE>

Registrable Securities offered by and sold under the registration statement
bears to the public offering price of all securities offered by and sold
under such registration statement, and the Company and other selling Holders
are responsible for the remaining portion; provided, however, that, in any
such case: (A) no such Holder will be required to contribute any amount in
excess of the public offering price of all such Registrable Securities
offered and sold by such Holder pursuant to such registration statement; and
(B) no person or entity guilty of fraudulent misrepresentation (within the
meaning of Section 11(f) of the Securities Act) will be entitled to
contribution from any person or entity who was not guilty of such fraudulent
misrepresentation.

(f)  Survival.  The obligations of the Company and Holders under this
Section 5 shall survive until the fifth anniversary of the completion of any
offering of Registrable Securities in a registration statement, regardless of
the expiration of any statutes of limitation or extensions of such statutes.

6.    TERMINATION OF THE COMPANY'S OBLIGATIONS.  The Company shall  have
no  obligations  pursuant  to  Section 2  with  respect  to  any  Registrable
Securities  proposed  to  be sold by a Holder in a registration  pursuant  to
Section 2 more than five (5) years after the date of this Agreement.






</TEXT>
</DOCUMENT>
